|
COCP Cocrystal Pharma Inc 1412486 |
| Income Statement |
|
Net Income
|
form10-q
|
-4,939,000 |
| Balance Sheet |
|
Current Assets
|
14,256,000 |
|
Assets
|
16,233,000 |
|
Current Liabilities
|
1,948,000 |
|
Liabilities
|
3,530,000 |
|
Equity
|
12,703,000 |
|
Shares Out
|
10,174,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-13,325,000 |
|
Investing Cash Flow
|
-8,000 |
| Market Analysis |
Market Cap
|
18,007,608 |
|
Price
|
1.54 |
|
BVPS
|
1.25 |
|
PB
|
1.24 |
|
EPS
|
-1.76 |
|
PS
|
1.14 |
|
FCF
|
-13,333,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view COCP documents filed with the SEC.
COCP Filings
Clear
